72 related articles for article (PubMed ID: 14587383)
1. [Time factors in postoperative radiotherapy in the years 1986-19990 and 2000-2002].
Milecki P; Kruk-Zagajewska A
Otolaryngol Pol; 2003; 57(4):483-7. PubMed ID: 14587383
[TBL] [Abstract][Full Text] [Related]
2. [Timing and duration of postoperative radiotherapy in patients with laryngeal cancer].
Milecki P; Kruk-Zagajewska A; Stryczyńska G
Otolaryngol Pol; 2002; 56(3):307-11. PubMed ID: 12162018
[TBL] [Abstract][Full Text] [Related]
3. [The influence of the duration of a break in the course of postoperative radiotherapy on the results of treatment of patients with total laryngectomy due to cancer].
Milecki P; Kruk-Zagajewska A; Szmeja Z; Cerkaska-Głuszak B
Otolaryngol Pol; 1997; 51(1):37-46. PubMed ID: 9518314
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic value of low hemoglobin concentration in adjuvant radiotherapy after total laryngectomy in group of patients with laryngeal cancer].
Milecki P; Kruk-Zagajewska A; Skowronek J
Przegl Lek; 2005; 62(12):1447-50. PubMed ID: 16786770
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of severity and clinical course of acute mucosal reaction during postop radiotherapy of laryngeal cancer].
Miszczyk L; Przeorek W
Otolaryngol Pol; 1999; 53(4):397-402. PubMed ID: 10581946
[TBL] [Abstract][Full Text] [Related]
6. Is the delay in starting postoperative radiotherapy a key factor in the outcome of advanced (T3 and T4) laryngeal cancer?
Marshak G; Rakowsky E; Schachter J; Shvero J; Feinmesser R; Sulkes A; Brenner B
Otolaryngol Head Neck Surg; 2004 Oct; 131(4):489-93. PubMed ID: 15467623
[TBL] [Abstract][Full Text] [Related]
7. Significance of laryngeal edema after partial laryngectomy and radiotherapy in supraglottic cancer.
Oksüz DC; Uzel O; Yildirim A; Yetmen O; Sahinler I; Turkan S
J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):681-8. PubMed ID: 19128676
[TBL] [Abstract][Full Text] [Related]
8. [The role of the gap in radiotherapy in the treatment of patients with laryngeal cancer].
Milecki P; Kruk-Zagajewska A
Otolaryngol Pol; 1996; 50(5):548-54. PubMed ID: 9053874
[TBL] [Abstract][Full Text] [Related]
9. [Pharyngocutaneous fistula as a complication after total laryngectomy--clinical study and literature review].
Rzepakowska A; Osuch-Wójcikiewicz E; Ochal-Choińska A; Bruzgielewicz A; Chęciński P; Nyckowska J; Szwedowicz P
Otolaryngol Pol; 2011 Sep; 65(5 Suppl):22-30. PubMed ID: 22000247
[TBL] [Abstract][Full Text] [Related]
10. Predictors of local failure in early laryngeal cancer.
Lohynska R; Slavicek A; Bahanan A; Novakova P
Neoplasma; 2005; 52(6):483-8. PubMed ID: 16284693
[TBL] [Abstract][Full Text] [Related]
11. Results of treatment of inoperable recurrences of laryngeal cancer after total laryngectomy.
Sas-Korczyńska B; Korzeniowski S; Skolyszewski J
Strahlenther Onkol; 1996 Feb; 172(2):99-102. PubMed ID: 8669051
[TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics and multivariate analysis of prognostic factors in recurrent laryngeal carcinoma].
Chen YF; Chen FJ; Yang AK; Zeng ZY; Song M; Li QL
Ai Zheng; 2004 May; 23(5):584-8. PubMed ID: 15142460
[TBL] [Abstract][Full Text] [Related]
13. Supracricoid laryngectomy outcomes: The Johns Hopkins experience.
Farrag TY; Koch WM; Cummings CW; Goldenberg D; Abou-Jaoude PM; Califano JA; Flint PW; Webster K; Tufano RP
Laryngoscope; 2007 Jan; 117(1):129-32. PubMed ID: 17202941
[TBL] [Abstract][Full Text] [Related]
14. [The results of salvage surgery in the patients with the laryngeal cancer after failed radiotherapy].
Piotrowski SM; Jordan J
Otolaryngol Pol; 2000; 54 Suppl 31():225-7. PubMed ID: 10974891
[TBL] [Abstract][Full Text] [Related]
15. [Treatment and prognosis of stage III-IV laryngeal squamous cell carcinoma].
Tian WD; Zeng ZY; Chen FJ; Wu GH; Guo ZM; Zhang Q
Ai Zheng; 2006 Jan; 25(1):80-4. PubMed ID: 16405756
[TBL] [Abstract][Full Text] [Related]
16. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.
Fung K; Lyden TH; Lee J; Urba SG; Worden F; Eisbruch A; Tsien C; Bradford CR; Chepeha DB; Hogikyan ND; Prince ME; Teknos TN; Wolf GT
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1395-9. PubMed ID: 16087298
[TBL] [Abstract][Full Text] [Related]
17. A single-institutional experience of 15 years of treating T3 laryngeal cancer with primary radiotherapy, with or without chemotherapy.
Al-Mamgani A; Tans L; van Rooij P; Levendag PC
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):1000-6. PubMed ID: 22099030
[TBL] [Abstract][Full Text] [Related]
18. Radiation therapy for stage I and II laryngeal cancer using 10 MV X-rays or cobalt-60 gamma-rays.
Hayakawa K; Mitsuhashi N; Tamaki Y; Takahashi M; Honjo J; Kamei T; Koyama I; Niibe H
Radiat Med; 1992; 10(5):199-205. PubMed ID: 1438927
[TBL] [Abstract][Full Text] [Related]
19. Transoral carbon dioxide laser supraglottic laryngectomy and irradiation in stage I, II, and III squamous cell carcinoma of the supraglottic larynx: report of Southwest Oncology Group Phase 2 Trial S9709.
Agrawal A; Moon J; Davis RK; Sakr WA; Giri SP; Valentino J; LeBlanc M; Truelson JM; Yoo GH; Ensley JF; Schuller DE;
Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1044-50. PubMed ID: 17938330
[TBL] [Abstract][Full Text] [Related]
20. Total laryngectomy and T3-T4 laryngeal cancer without other adverse histopathology.
Ampil FL; Nathan CO; Lian TS; Caldito G; Milligan E
Otolaryngol Head Neck Surg; 2007 Feb; 136(2):296-300. PubMed ID: 17275558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
